Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hak Choy

Showing results (111-120 of 140) with videos related to

Pageof 14
Sort By:
Practical Radiation Oncology|February 12, 2022
A How-To Compendium for GammaPod Treatments, Clinical Workflow, and Clinical Program at an Early Adopting InstitutionElizabeth Zhang-Velten, You Zhang, Sepeadeh Radpour, et al.
Practical Radiation Oncology|May 10, 2015
Adjuvant radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guidelineGeorge Rodrigues, Hak Choy, Jeffrey Bradley, et al.
Practical Radiation Oncology|May 10, 2015
Definitive radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guidelineGeorge Rodrigues, Hak Choy, Jeffrey Bradley, et al.
Cancer Investigation|November 29, 2016
A Phase I/II Study of Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Squamous Cell Cancer of the Head and NeckStephen G Chun, Randall Hughes, Baran D Sumer, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2019
Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell CancerYuanyuan Zhang, Jonathan Schoenhals, Alana Christie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2014
Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancerPuneeth Iyengar, Brian D Kavanagh, Zabi Wardak, et al.
International Journal of Radiation Oncology, Biology, Physics|January 27, 2019
A Phase 2 Clinical Trial of SABR Followed by Immediate Vertebroplasty for Spine MetastasesZabi Wardak, Ross Bland, Chul Ahn, et al.
European Urology Oncology|August 19, 2022
Stereotactic Ablative Radiation for Systemic Therapy-naïve Oligometastatic Kidney CancerRaquibul Hannan, Michael Christensen, Alana Christie, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexusFeng-Ming Spring Kong, Timothy Ritter, Douglas J Quint, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2015
Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation TrialKenneth D Westover, Billy W Loo, David E Gerber, et al.
Pageof 14

Showing results (111-120 of 140) with videos related to

Sort By:
Pageof 14
Practical Radiation Oncology|February 12, 2022
A How-To Compendium for GammaPod Treatments, Clinical Workflow, and Clinical Program at an Early Adopting InstitutionElizabeth Zhang-Velten, You Zhang, Sepeadeh Radpour, et al.
Practical Radiation Oncology|May 10, 2015
Adjuvant radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guidelineGeorge Rodrigues, Hak Choy, Jeffrey Bradley, et al.
Practical Radiation Oncology|May 10, 2015
Definitive radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guidelineGeorge Rodrigues, Hak Choy, Jeffrey Bradley, et al.
Cancer Investigation|November 29, 2016
A Phase I/II Study of Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Squamous Cell Cancer of the Head and NeckStephen G Chun, Randall Hughes, Baran D Sumer, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2019
Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell CancerYuanyuan Zhang, Jonathan Schoenhals, Alana Christie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2014
Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancerPuneeth Iyengar, Brian D Kavanagh, Zabi Wardak, et al.
International Journal of Radiation Oncology, Biology, Physics|January 27, 2019
A Phase 2 Clinical Trial of SABR Followed by Immediate Vertebroplasty for Spine MetastasesZabi Wardak, Ross Bland, Chul Ahn, et al.
European Urology Oncology|August 19, 2022
Stereotactic Ablative Radiation for Systemic Therapy-naïve Oligometastatic Kidney CancerRaquibul Hannan, Michael Christensen, Alana Christie, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexusFeng-Ming Spring Kong, Timothy Ritter, Douglas J Quint, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2015
Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation TrialKenneth D Westover, Billy W Loo, David E Gerber, et al.
Pageof 14